Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.Shawn D. Aaron, Mark Fitzgerald, Andrew McIvor et al.|PubMed|2007Cited by 653
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A. Hanania, John G. Matthews, Phillip E. Korenblat et al.|The Lancet Respiratory Medicine|2016Cited by 465
Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD studyWan C. Tan, Shawn D. Aaron, Don D. Sin et al.|Thorax|2015Cited by 249
Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering ApproachEileen Wang, Bassam Mahboub, William Henley et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 1